http://www.sciaconference.com/PublicCo/June2010/Arrayit/Index.html
There were 5 additional companies presenting also.
These are the blockbuster Arrayit tests in the pipeline:
OvaDx-FDA submission Q3 '10-Expect approval Q4'10 Est.Revenue $5.B
VIP for Plavix - FDA submission Q1 2011 - Estimated Revenue $900M
Parkinson's disease - FDA submission Q2 2011 - Est. Revenue $500M
Prostate cancer - FDA submission Q4 2011 - Est. Revenue $1.5B
Last slide is exciting:
- Arrayit can become one of America's most valuable companies:
- There are 6000 known human diseases.
- Arrayit can develop a molecular test for each disease.
- 10% market share = 600 tests
- $100M annual revenue per test = $60B in sales
- $60B in sales @ 5 times sales = $300B market cap
- Arrayit can be the next APPLE
End of slide
-------------------
It is amazing that with this potential, and @ 0.70 per share, as of 12:00 noon ZERO shares have trade in the market TODAY.
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM